title: The analysis by Manuel and colleagues creates controversy with headlines, not data.
authors.affiliation: Division of Cardiology, Royal Victoria Hospital, McGill University, Montréal, Que. jacques.genest@muhc.mcgill.ca
authors.forename: Jacques
authors.initials: J
authors.lastname: Genest
authors.forename: Ruth
authors.initials: R
authors.lastname: McPherson
authors.forename: Jiri
authors.initials: J
authors.lastname: Frohlich
authors.forename: George
authors.initials: G
authors.lastname: Fodor
mesh_terms: D002170:Canada; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000401:mortality / Q000517:prevention & control*; D005102:Health Expenditures; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012307:Risk Factors
chemical_list: D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents